The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 16(2) of Directive 98/8/EC. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.    ,

IPBC,  IUPAC Name:    3-iodo-2-propynyl butylcarbamate    EC No: 259-627-5    CAS No: 55406-53-6  ,980 g/kg,1 December 2016,30 November 2026,13,  The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.    The authorisations of biocidal products are subject to the following conditions:      For professional users, safe operational procedures and appropriate organizational measures shall be established. Products shall be used with appropriate personal protective equipment where exposure cannot be reduced to an acceptable level by other means,.      In view of the risks to the professional users, loading of the products into metal working fluids shall be semi-automated or automated, unless it can be demonstrated that risks can be reduced to an acceptable level by other means.      The placing on the market of treated articles is subject to the following condition:    The person responsible for the placing on the market of a treated article treated with or incorporating IPBC shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of the Regulation (EU) No 528/2012.  ,